AstraZeneca Ultomiris approved in Europe for treatment of adults with generalised myasthenia gravis Ruchika Sharma25 Sept 2022 12:00 PM ISTUltomiris (ravulizumab), the first and only long-acting C5 complement inhibitor, offers immediate, complete and sustained complement inhibition.
AstraZeneca, Merck get Chinese nod for Lynparza to treat ovarian cancer Ruchika Sharma24 Sept 2022 3:24 PM ISTIn China, Lynparza is approved for the treatment of BRCA-mutated metastatic castration-resistant prostate cancer as well as a 1st-line maintenance...
AstraZeneca Severe Asthma treatment Tezspire gets nod in EU Ruchika Sharma22 Sept 2022 2:00 PM ISTTezspire (tezepelumab) is being developed by AstraZeneca in collaboration with Amgen.
AstraZeneca Evusheld approved in EU for treatment of COVID Ruchika Sharma20 Sept 2022 2:30 PM ISTThe recommended dose of Evusheld for treatment in Europe is 300mg of tixagevimab and 300mg of cilgavimab, administered as two separate, sequential IM...
EMA Committee recommends nod of Sanofi, AstraZeneca Beyfortus for prevention of RSV disease in infants Ruchika Sharma18 Sept 2022 3:00 PM ISTParis: Sanofi and AstraZeneca have recently announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has...
AstraZeneca Evusheld recommended for approval in EU for treatment of COVID-19 Ruchika Sharma17 Sept 2022 3:30 PM ISTThe recommended dose of Evusheld for treatment in the EU is 300mg of tixagevimab and 300mg of cilgavimab, administered as two separate, sequential IM...
AstraZeneca unveils iPHARMACY to up-skill pharmacists across India Ruchika Sharma15 Sept 2022 12:00 PM ISTThe program will focus on inventory management, good pharmacy practices, customization of pharmacy for patient of future, and management of pharmacy...
AstraZeneca beats US shareholder lawsuit over COVID vaccine disclosures Ruchika Sharma13 Sept 2022 4:00 PM ISTUS District Judge Paul Oetken said AstraZeneca and its executives had no "generalized duty" to disclose "negative facts" about the trials.
AstraZeneca Lynparza shows clinically meaningful survival benefit in 1st-line advanced ovarian cancer across two Phase III trials Ruchika Sharma11 Sept 2022 1:15 PM ISTOvarian cancer is one of the most common gynaecologic cancers, with a poor prognosis and a high mortality rate.
AstraZeneca Forxiga gets Chinese nod to treat CKD with and without type 2 diabetes Ruchika Sharma6 Sept 2022 11:15 AM ISTForxiga (dapagliflozin) is a first-in-class, oral, once-daily SGLT2 inhibitor.
AstraZeneca gets USFDA nod for Imfinzi plus chemotherapy to treat advanced biliary tract cancer Ruchika Sharma5 Sept 2022 1:30 PM ISTBiliary tract cancer is a group of rare and aggressive cancers that occur in the bile ducts and gallbladder.
AstraZeneca Tagrisso gets Japanese okay for early-stage EGFR-mutated lung cancer Ruchika Sharma30 Aug 2022 9:45 AM ISTNew Delhi: AstraZeneca's Tagrisso (osimertinib) has been approved in Japan for the adjuvant treatment of patients with epidermal growth factor...
